← Back to headlines
BioNTech Grapples with Falling Demand and Restructuring Post-Pandemic
BioNTech, once celebrated for its COVID-19 vaccines, is facing challenges including falling demand, restructuring, and the departure of its founders, as it shifts focus to ambitious cancer trials.
7 May, 13:03 — 7 May, 13:03
